-
Loading metrics
Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT)
-
Mehdi Brahmi,
Roles Investigation, Writing – review & editing
Affiliation Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France
⨯ -
Philippe Cassier,
Roles Investigation, Writing – review & editing
Affiliation Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France
⨯ - Armelle Dufresne,
- Sylvie Chabaud,
- Marie Karanian,
- Alexandra Meurgey,
-
Amine Bouhamama,
Roles Investigation, Writing – review & editing
Affiliation Department of Radiology, Léon Bérard Cancer Center, Lyon, France
⨯ - Francois Gouin,
- Gualter Vaz,
- Jerome Garret,
- Marie-Pierre Sunyach,
-
Aurélien Dupré,
Roles Investigation, Resources, Writing – review & editing
Affiliation Department of Surgery, Léon Bérard Cancer Center, Lyon, France
⨯ - Perrine Marec-Berard,
- Nadège Corradini,
- David Perol,
- Isabelle Ray-Coquard,
- [ ... ],
-
Jean-Yves Blay
Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Supervision, Validation, Writing – original draft, Writing – review & editing
* E-mail: jean-yves.blay@lyon.unicancer.fr
Affiliations Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France, University Claude Bernard, Lyon, France
⨯ - [ view all ]
- [ view less ]
http://orcid.org/0000-0001-9904-166X
Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT)
- Mehdi Brahmi,
- Philippe Cassier,
- Armelle Dufresne,
- Sylvie Chabaud,
- Marie Karanian,
- Alexandra Meurgey,
- Amine Bouhamama,
- Francois Gouin,
- Gualter Vaz,
- Jerome Garret
- Published: May 20, 2020
- https://doi.org/10.1371/journal.pone.0233046